USA, multiple locations - 10 Sep `20Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

 

Official Title: Multi-Arm Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

In Brief: This is a prospective study to evaluate the application of Spray-On Skin™ Cells, prepared using the RECELL® Device for safe and effective repigmentation of ablated stable vitiligo lesions.

Ages Eligible: 18 Years and older 

Start Date: September 10, 2020

Completion Date (estimated): March 2023

Status: Recruiting

Study ID from ClinicalTrials.gov: NCT04547998
Other Study ID Numbers: CTP009

Locations:

  • Irvine, CA
  • Greenwood Village, CO
  • Miami, FL
  • Worcester, MA
  • Detroit, MI

Contact: To learn more about this study, you or your doctor may contact 

Elizabeth Kirshner
6613676869
ekirshner@avitamedical.com
 
Lisa Carothers
6614814663
lcarothers@avitamedical.com

Please refer to this study by its NCT number.

FAQOther Questions

  • Are there any famous people with vitiligo?

    Many celebrities have dealt with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career. Here are a few courageous famous peo...

  • Which skin conditions can be mistaken for vitiligo?

    Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...

  • What is vitiligo?

    Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...